Skip to main content
Watch Insiders

Corporate insider profile

Marshall Urist Insider Trades

Latest reported as EVP, Research & Investments of Royalty Pharma plc (RPRX).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,932,903.38
Latest transaction
Oct 5, 2026

Affiliated corporations

Reported company relationships

RPRXLatest reported

Royalty Pharma plc

EVP, Research & Investments

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 5, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale4,126$57.10$235,595
Sep 28, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale4,126$57.88$238,813
Jul 1, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale9,099$55.88$508,454
Jun 24, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale9,098$55.18$502,067
May 20, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale13,684$52.75$721,838
May 14, 2026Royalty Pharma plc (RPRX)EVP, Research & InvestmentsSale13,684$53.06$726,137